XML 69 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1

SEGMENT INFORMATION (Tables)

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Schedule of Information About Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income

The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated income before provision for income taxes ("pre-tax income") (in millions):

	Years Ended December 31,
	2018				2017				2016
Net Sales Reconciliation
Segment net sales	$	3,676.0			$	3,422.1			$	2,944.8
Foreign currency	46.8				13.2				18.9
Consolidated net sales	$	3,722.8			$	3,435.3			$	2,963.7
Pre-tax Income Reconciliation
Segment operating income	$	2,115.5			$	1,914.6			$	1,623.7
Unallocated amounts:
Corporate items	(1,052.4		)		(893.6		)		(821.6		)
Special charges, net	(116.2		)		(9.7		)		(34.5		)
Intellectual property litigation (expenses) income, net	(214.0		)		73.3				(32.6		)
Foreign currency	15.3				4.8				16.2
Consolidated operating income	748.2				1,089.4				751.2
Non-operating income (expense)	13.2				(54.5		)		(13.3		)
Consolidated pre-tax income	$	761.4			$	1,034.9			$	737.9

The table below presents information about Edwards Lifesciences' reportable segments (in millions):

	Years Ended December 31,
	2018				2017				2016
Segment Net Sales
United States	$	2,055.2			$	1,907.6			$	1,615.7
Europe	826.4				800.7				745.9
Japan	398.4				356.5				279.6
Rest of World	396.0				357.3				303.6
Total segment net sales	$	3,676.0			$	3,422.1			$	2,944.8
Segment Operating Income
United States	$	1,368.1			$	1,242.3			$	1,050.2
Europe	394.8				378.4				360.9
Japan	237.0				201.1				139.6
Rest of World	115.6				92.8				73.0
Total segment operating income	$	2,115.5			$	1,914.6			$	1,623.7

Schedule of Enterprise-Wide Information

Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.

	As of or for the Years Ended December 31,
	2018				2017				2016
	(in millions)
Net Sales by Geographic Area
United States	$	2,055.3			$	1,907.6			$	1,615.7
Europe	885.1				831.0				749.0
Japan	396.8				350.3				309.3
Rest of World	385.6				346.4				289.7
	$	3,722.8			$	3,435.3			$	2,963.7
Net Sales by Major Product Area
Transcatheter Heart Valve Therapy	$	2,286.7			$	2,027.2			$	1,628.5
Surgical Heart Valve Therapy	761.6				807.1				774.9
Critical Care	674.5				601.0				560.3
	$	3,722.8			$	3,435.3			$	2,963.7
Long-lived Tangible Assets by Geographic Area
United States	$	642.1			$	608.7			$	555.5
Europe	36.6				28.4				27.9
Japan	6.7				7.6				8.0
Rest of World	214.4				139.7				108.6
	$	899.8			$	784.4			$	700.0

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration